HNPP is one of the most controversial neurological disorders in the field of the nervous system, with clinical performance being complex and often involving multi-system fatigue. Early identification and standardized diagnosis are essential for improving prognosis. The diagnosis of the disease requires a combination of clinical performance, imaging inspection, laboratory testing and pathological activation.
The platform can assist in bringing together a team of authoritative experts at home and abroad to provide accurate diagnosis and treatment programs. In recent years, with the development of therapeutic, immune-regulatory therapy and precision medicine, many diseases of the nervous system that have previously been difficult to treat have been significantly improved. Treatment needs to be closely monitored for efficacy and adverse reactions, adapted to the timely schedule according to the changes in the disease.
Multidisciplinary collaboration (MDT) is particularly important for the integrated management of the HNPP for hereditary oppressive susceptible neurological diseases. 2. Visiting China: arranging face-to-face treatment with authoritative experts, developing individualized treatment plans; 3.
Full-service: providing one-stop services such as medical translation, medical care, accommodation arrangements; 4. Long-term follow-up: establishing a chronic disease management archive, continuous monitoring of disease changes and treatment effects.